Cardinal Health Inc CAH reported better-than-expected fourth-quarter earnings and raised its guidance.
Cardinal Health reported fourth-quarter adjusted EPS of $1.55, up 48% Y/Y, beating the consensus of $1.48. Sales increased 13% to $53.45 billion, beating the consensus of $52.41 billion.
Cardinal Health raised its FY24 adjusted EPS guidance to $6.50-$6.75 from prior guidance of $6.45-$6.70 versus consensus of $6.59.
Cardinal Health shares lost 2.6% to close at $90.57 on Tuesday.
These analysts made changes to their price targets on Cardinal Health following earnings announcement.
- Mizuho increased the price target on Cardinal Health from $94 to $96. Mizuho analyst Ann Hynes maintained a Neutral rating.
- Baird raised the price target on Cardinal Health from $107 to $108. Baird analyst Eric Coldwell maintained an Outperform rating.
Now Read This: TJX, Mercury Systems And 3 Stocks To Watch Heading Into Wednesday
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.